Clinical Trials Browser

Enrolling by invitation × Bendamustine Hydrochloride × 1 year × Clear all

NCT06931613 2025-04-17

Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment

Phase 2 Enrolling by invitation

Hodgkin Disease, Recurrence